Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / December / Beyond the Biopsy / Summary
Biochemistry and molecular biology Liquid biopsy Precision medicine Technology and innovation

Beyond the Biopsy

Merging spatial and systemic biomarkers for precision medicine

By Shana Tetrault 12/02/2025 Review 4 min read
article Full Article Summary Notecard

Share

The evolving precision medicine landscape leverages advanced technologies for nuanced disease understanding and tailored treatments. It combines spatial proteomics, which visualizes protein expression in tissue, with ultra-sensitive blood-based protein quantification. This integration enhances diagnostics, particularly in oncology and autoimmune diseases, by linking tissue context with systemic responses. Enhanced reproducibility through standardized protocols fosters clinical trust, while streamlined workflows make these technologies more accessible, ultimately optimizing patient outcomes through proactive and personalized care.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Shana Tetrault

Shana Tetrault, PhD, is Senior Director of Product Marketing, Quanterix.

More Articles by Shana Tetrault

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.